ketoconazole has been researched along with Vaginitis in 8 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Vaginitis: Inflammation of the vagina characterized by pain and a purulent discharge.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effectiveness of the combination of ketoconazol 400 mg + clindamycin 100 mg for 6 days compared to ketoconazol 800 mg + clindamycin 100 mg in Candida vaginitis and bacterial vaginosis." | 9.11 | [Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis]. ( Garibay, M; Godínez, V; Mirabent, F; Pérez Calderón, A, 2005) |
| "90% of polled Latin-American obstetricians prescribe clyndamicin plus ketoconazole as the best available treatment to mixed vaginitis." | 7.74 | [Mixed vaginitis prevalence in Latin-American women, according to physician perception. Preference, effectiveness and security of clindamycin plus ketoconazole]. ( De Zordo, D; Dumet Hinostroza, PF; Gutiérrez Ramos, M; Hernández Bueno, JA; Olguín Ramírez, C; Vázquez Alanís, A, 2008) |
| "To evaluate the effectiveness of the combination of ketoconazol 400 mg + clindamycin 100 mg for 6 days compared to ketoconazol 800 mg + clindamycin 100 mg in Candida vaginitis and bacterial vaginosis." | 5.11 | [Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis]. ( Garibay, M; Godínez, V; Mirabent, F; Pérez Calderón, A, 2005) |
| " The dosage and therapeutic duration were as follows: Flu 200-400 mg daily for 1-8 weeks in 34 patients with fungal infection and 150 mg as a single dose in 30 patients with fungal vaginitis; Keto 400 mg daily for 1-8 weeks in 30 patients with fungal diseases and for 5 days in 30 patients with fungal vaginitis." | 2.68 | [Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study]. ( Liang, D; Lu, Y; Zhang, H, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernández Bueno, JA | 1 |
| Vázquez Alanís, A | 1 |
| Olguín Ramírez, C | 1 |
| Dumet Hinostroza, PF | 1 |
| Gutiérrez Ramos, M | 1 |
| De Zordo, D | 1 |
| Zhang, H | 2 |
| Wang, K | 1 |
| Zhang, G | 1 |
| Ho, HI | 1 |
| Gao, A | 1 |
| Looi, CY | 1 |
| D' Silva, EC | 1 |
| Seow, HF | 1 |
| Rosli, R | 1 |
| Ng, KP | 1 |
| Chong, PP | 1 |
| Godínez, V | 1 |
| Garibay, M | 1 |
| Mirabent, F | 1 |
| Pérez Calderón, A | 1 |
| Dame, WR | 1 |
| Schweppe, KW | 1 |
| Lu, Y | 1 |
| Liang, D | 1 |
| Adám, J | 1 |
| Ba, J | 1 |
| Bingham, JS | 1 |
2 trials available for ketoconazole and Vaginitis
| Article | Year |
|---|---|
[Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clindamycin; Double-Blind | 2005 |
[Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Double-Blind Method; Female; Fluconaz | 1997 |
6 other studies available for ketoconazole and Vaginitis
| Article | Year |
|---|---|
[Mixed vaginitis prevalence in Latin-American women, according to physician perception. Preference, effectiveness and security of clindamycin plus ketoconazole].
Topics: Anti-Bacterial Agents; Antifungal Agents; Clindamycin; Cross-Sectional Studies; Drug Combinations; F | 2008 |
Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study.
Topics: Animals; Antifungal Agents; Benzylisoquinolines; Candida albicans; Candidiasis, Vulvovaginal; Colony | 2010 |
Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
Topics: Antifungal Agents; Base Sequence; Candida albicans; Candida glabrata; Candidiasis; Clotrimazole; DNA | 2005 |
[Experiences with the oral antimycotic ketoconazole in vaginal fungal involvement].
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Human | 1982 |
Treatment of vaginal discharge caused by blastomycetes with nizoral tablet.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Ketoconazole; Leukorrhea | 1986 |
Vulvo-vaginal candidosis--an overview.
Topics: Candidiasis, Vulvovaginal; Coitus; Diabetes Complications; England; Epidemiologic Methods; Female; H | 1986 |